As of Apr 23, 2024, the CRL stock has a PE ratio of 25.9. The calculation is based on the latest EPS of $9.27 and the stock price of $240.13 per share. An increase of 16% has been observed in the PE ratio compared to its average of 22.3 of the last four quarters.
The mean historical PE ratio of Charles River Laboratories International over the last ten years is 29.9. The current 25.9 P/E ratio is 13% lower than the historical average. Looking back at the last ten years, CRL's PE ratio peaked in the Sep 2021 quarter at 57.87, with a price of $458.3 and an EPS of $7.92. The Apr 2023 quarter marked the lowest point at 20.68, with a price of $201.82 and an EPS of $9.76.
Maximum annual increase: 81.78% in 2017
Maximum annual decrease: -52.08% in 2022
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 25.5 | 11.99% |
| 2022 | 22.77 | -52.08% |
| 2021 | 47.52 | 38.74% |
| 2020 | 34.25 | 16.54% |
| 2019 | 29.39 | 24.17% |
| 2018 | 23.67 | -43.78% |
| 2017 | 42.1 | 81.78% |
| 2016 | 23.16 | -7.17% |
| 2015 | 24.95 | 5.54% |
| 2014 | 23.64 | -4.68% |
CRL's current PE ratio is lower than its 3, 5 and 10-year averages.
In comparison to its peers TMO and RGEN, CRL's PE ratio is lower, but it is higher than SCYX's.
| Stock name | PE ratio | Market cap |
|---|---|---|
| SCYX Scynexis Inc | 1.11 | $58.52M |
| CRL Charles River Laboratories International Inc | 25.9 | $12.33B |
| TMO Thermo Fisher Scientific Inc | 37.02 | $219.1B |
| RGEN Repligen Corp | 228.37 | $9.55B |
CRL stock has a price to earnings ratio of 25.9 as of Apr 23, 2024.
As an average over the last 3 years, CRL stock has a PE ratio of 31.34.
As an average over the last 5 years, CRL stock has a PE ratio of 31.41.
Over the last ten years, the Sep 2021 quarter recorded the highest quarterly PE ratio at 57.87.
CRL's current price to earnings ratio is 13% below its 10-year historical average.
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Apr 23, 2024), Charles River Laboratories International's share price is $240.13. The company's earnings per share for the trailing twelve months (TTM) ending Dec 2023 is $9.27. Therefore, Charles River Laboratories International's PE ratio for today is 25.9. PE RATIO(25.9) = STOCK PRICE($240.13) / TTM EPS($9.27)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.